These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2804550)

  • 1. Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.
    Wanstall JC; O'Donnell SR
    Br J Pharmacol; 1989 Sep; 98(1):302-8. PubMed ID: 2804550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed.
    Perretti F; Nediani C; Manzini S
    Arch Int Pharmacodyn Ther; 1990; 306():87-99. PubMed ID: 1963768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD; Arena E; Macia RA; Bugelski PJ; Matthews WD; Morgan DG
    Toxicol Pathol; 1989; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels.
    Bhardwaj R; Moore PK
    Br J Pharmacol; 1988 Nov; 95(3):835-43. PubMed ID: 3264734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists.
    Warner TD
    Br J Pharmacol; 1990 Feb; 99(2):427-33. PubMed ID: 2328405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical localization of the binding and functional characterization of responses to dopexamine hydrochloride in the rat mesenteric vasculature.
    Amenta F; Ricci A; Napoleone P; Vyas SJ; Lokhandwala MF
    Pharmacology; 1991; 42(4):211-22. PubMed ID: 1677201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for reduced beta-adrenoceptor coupling to adenylate cyclase in femoral arteries from spontaneously hypertensive rats.
    Asano M; Masuzawa K; Matsuda T
    Br J Pharmacol; 1988 May; 94(1):73-86. PubMed ID: 2456812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat.
    Nichols AJ; Hiley CR
    J Pharm Pharmacol; 1985 Feb; 37(2):110-5. PubMed ID: 2858542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antagonism of D1-receptor-mediated vasodilator response in the perfused kidney by SCH23390.
    Martin SW; Broadley KJ
    Pharmacol Res; 1995 May; 31(5):289-97. PubMed ID: 7479526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between dopamine and prostaglandins on vascular reactivity to noradrenaline: dopamine inhibits the action of PGE1.
    Oka M; Manku MS; Horrobin DF
    Prostaglandins Med; 1981 Oct; 7(4):267-80. PubMed ID: 6947304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroxine treatment of aged or young rats demonstrates that vascular responses mediated by beta-adrenoceptor subtypes can be differentially regulated.
    O'Donnell SR; Wanstall JC
    Br J Pharmacol; 1986 May; 88(1):41-9. PubMed ID: 2871884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
    Gray DW; Marshall I
    Br J Pharmacol; 1992 Nov; 107(3):684-90. PubMed ID: 1335334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat.
    Heesen BJ; De Mey JG
    Br J Pharmacol; 1990 Dec; 101(4):859-64. PubMed ID: 1707706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aging and hypertension on vasorelaxant activity of calcitonin gene-related peptide: a comparison with other vasodilator agents.
    Amerini S; Mantelli L; Filippi S; Ledda F
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):432-7. PubMed ID: 7515987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the vasoconstrictor responses to potassium depolarization and norepinephrine and their antagonism by differing classes of vasodilators in the perfused rat hindquarters.
    Sybertz EJ; Vander Vliet G; Baum T
    J Pharmacol Exp Ther; 1983 Dec; 227(3):621-6. PubMed ID: 6317841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor.
    McLaughlin DP; MacDonald A
    Br J Pharmacol; 1991 Jun; 103(2):1351-6. PubMed ID: 1679358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.